×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
OPTN – optinose, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
OPTN
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/7
01:04 pm
optn
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OPTN, SLRN, AKYA, SHYF on Behalf of Shareholders
Low
Report
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OPTN, SLRN, AKYA, SHYF on Behalf of Shareholders
4/4
07:00 pm
optn
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger – OPTN, SLRN, AKYA, SHYF
Neutral
Report
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger – OPTN, SLRN, AKYA, SHYF
3/26
07:00 am
optn
Optinose Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Operational Highlights
Low
Report
Optinose Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Operational Highlights
3/22
07:54 am
optn
OptiNose, Inc. (NASDAQ: OPTN) was downgraded by analysts at Piper Sandler from a "strong-buy" rating to a "hold" rating.
Low
Report
OptiNose, Inc. (NASDAQ: OPTN) was downgraded by analysts at Piper Sandler from a "strong-buy" rating to a "hold" rating.
3/21
04:34 pm
optn
OPTINOSE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of OptiNose, Inc. - OPTN
Low
Report
OPTINOSE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of OptiNose, Inc. - OPTN
3/21
11:31 am
optn
OptiNose, Inc. (NASDAQ: OPTN) had its "neutral" rating re-affirmed by analysts at Piper Sandler. They now have a $9.00 price target on the stock, down previously from $15.00.
Low
Report
OptiNose, Inc. (NASDAQ: OPTN) had its "neutral" rating re-affirmed by analysts at Piper Sandler. They now have a $9.00 price target on the stock, down previously from $15.00.
3/21
09:40 am
optn
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BECN and OPTN on Behalf of Shareholders
Low
Report
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BECN and OPTN on Behalf of Shareholders
3/21
08:09 am
optn
OptiNose, Inc. (NASDAQ: OPTN) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock, down previously from $18.00.
Low
Report
OptiNose, Inc. (NASDAQ: OPTN) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock, down previously from $18.00.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/3
06:40 am
optn
Form PREM14A OptiNose, Inc. For: Apr 02
Low
Report
Form PREM14A OptiNose, Inc. For: Apr 02
3/26
07:19 am
optn
Form 10-K OptiNose, Inc. For: Dec 31
Low
Report
Form 10-K OptiNose, Inc. For: Dec 31
3/26
07:05 am
optn
Form 8-K OptiNose, Inc. For: Mar 26
Low
Report
Form 8-K OptiNose, Inc. For: Mar 26
3/20
09:15 am
optn
Form 8-K OptiNose, Inc. For: Mar 19
Medium
Report
Form 8-K OptiNose, Inc. For: Mar 19
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/19
OptiNose Inc (NASDAQ: OPTN) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating.
21.8%
8/12 Form 10-Q OptiNose, Inc. For: Jun 30 15.9%
7/9 Form 4 OptiNose, Inc. For: Jun 28 Filed by: Goldan Keith A. 10.2%
11/1 Optinose to Report Third Quarter 2019 Financial Results and Corporate Updates on November 12, 2019 9.0%
6/19 Optinose Named a 2019 Best Place to Work by Philadelphia Business Journal 8.5%
2/18 Form 8-K OptiNose, Inc. For: Feb 13 8.0%
1/15 OptiNose Inc (NASDAQ: OPTN) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $9.00 price target on the stock. 7.2%
9/12 Optinose Announces $150 Million Debt Financing from Pharmakon 6.6%
4/29 Form DEF 14A OptiNose, Inc. For: Dec 31 4.5%
11/12 Optinose, Inc.'s (OPTN) CEO Peter Miller on Q3 2019 Results - Earnings Call Transcript [Seeking Alpha] 4.4%
8/12 Form 10-Q OptiNose, Inc. For: Jun 30 15.9%
7/9 Form 4 OptiNose, Inc. For: Jun 28 Filed by: Goldan Keith A. 10.2%
11/1 Optinose to Report Third Quarter 2019 Financial Results and Corporate Updates on November 12, 2019 9.0%
6/19 Optinose Named a 2019 Best Place to Work by Philadelphia Business Journal 8.5%
2/18 Form 8-K OptiNose, Inc. For: Feb 13 8.0%
1/15 OptiNose Inc (NASDAQ: OPTN) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $9.00 price target on the stock. 7.2%
9/12 Optinose Announces $150 Million Debt Financing from Pharmakon 6.6%
4/29 Form DEF 14A OptiNose, Inc. For: Dec 31 4.5%
11/12 Optinose, Inc.'s (OPTN) CEO Peter Miller on Q3 2019 Results - Earnings Call Transcript [Seeking Alpha] 4.4%
TOP News Decliners
5/9
Q1/2019 3/31/2019 EPS -0.700 ZacksConsensus -0.710 ActVsEst 0.010 - Beat
-14.3%
11/20 Optinose Announces Proposed Public Offering of Common Stock -12.6%
3/5 OptiNose, Inc. 2019 Q4 - Results - Earnings Call Presentation [Seeking Alpha] -10.8%
8/1 Optinose to Report Second Quarter 2019 Financial Results and Corporate Updates on August 12, 2019 -8.4%
1/2 OptiNose Inc (NASDAQ: OPTN) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $11.00 price target on the stock. -8.1%
9/27 Optinose to Present at the 2019 Cantor Global Healthcare Conference -6.5%
2/27 Optinose to Report Fourth Quarter and Full Year 2019 Financial Results and Corporate Updates on March 5, 2020 -6.2%
3/9 Form S-8 OptiNose, Inc. -5.7%
2/21 OptiNose Inc (NASDAQ: OPTN) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. -5.4%
3/11 OptiNose Inc (NASDAQ: OPTN) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -5.4%
11/20 Optinose Announces Proposed Public Offering of Common Stock -12.6%
3/5 OptiNose, Inc. 2019 Q4 - Results - Earnings Call Presentation [Seeking Alpha] -10.8%
8/1 Optinose to Report Second Quarter 2019 Financial Results and Corporate Updates on August 12, 2019 -8.4%
1/2 OptiNose Inc (NASDAQ: OPTN) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $11.00 price target on the stock. -8.1%
9/27 Optinose to Present at the 2019 Cantor Global Healthcare Conference -6.5%
2/27 Optinose to Report Fourth Quarter and Full Year 2019 Financial Results and Corporate Updates on March 5, 2020 -6.2%
3/9 Form S-8 OptiNose, Inc. -5.7%
2/21 OptiNose Inc (NASDAQ: OPTN) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. -5.4%
3/11 OptiNose Inc (NASDAQ: OPTN) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -5.4%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: